Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Optional Follow-Up Study to Evaluate the Continued Efficacy of ToleroMune HDM in House Dust Mite Allergic Subjects Following Challenge With House Dust Mite Allergen in an Environmental Exposure Chamber

NCT01923792 is registered in ClinicalTrials.gov with Circassia Limited as lead sponsor.

NCT NCT01923792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Optional Follow-Up Study to Evaluate the Continued Efficacy of ToleroMune HDM in House Dust Mite Allergic Subjects Following Challenge With House Dust Mite Allergen in an Environmental Exposure Chamber
Lead sponsor
Circassia Limited
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
April 30, 2014
Enrollment
105 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

house dust mite allergy, rhinoconjunctivitis